Condition: Osteoporosis, Postmenopausal · Osteoporosis Fracture · Osteoporosis, Severe · Sponsor: National and Kapodistrian University of Athens
This study aims to discover novel biomarkers and therapeutic targets for osteoporosis through the use of advanced omics technologies, including proteomics and metabolomics. By analyzing bone and plasma samples from patients with osteoporosis, the research seeks to understand the underlying mechanisms of the disease and identify potential diagnostic and therapeutic biomarkers.
This description comes directly from the study's public registry record.
Efstathios Chronopoulos · 00306944837793 · stathi24@yahoo.gr
Stavros Lykos · 00306978695466 · lykosstavros@gmail.com
Always discuss trial participation with your own doctor first.
| Laboratory for Research of the Musculoskeletal System | Kifissia, Attica, Greece | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06525688